Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Different genes are linked to various types of hair loss.

Genetic discoveries are leading to new treatments for alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Skin bacteria can help wound healing by activating certain immune cells.

New research is helping develop better treatments for alopecia areata.

Melatonin affects different genes and pathways important for goat hair growth.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Mouse models help understand alopecia areata and find treatments.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.